Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Marksans Pharma Ltd.

Price on BSE   20 Mar,11:46 LIVE
169.25
+7.95
(+4.93%)

© 2026 Rediff.com
  • Volume :
  • 27,204.00
  • Prev Close :
  • 161.30
  • Day's H/L (Rs.) :
  • 169.30 - 161.70
  • 52wk H/L (Rs.) :
  • 270.60 - 157.25
  • Mkt Cap (Rs. Cr) :
  • 7,670.41
Price on NSE   20 Mar,12:16 LIVE
168.33
+6.92
(+4.29%)

© 2026 Rediff.com
  • Volume :
  • 402,694.00
  • Prev Close :
  • 161.41
  • Day's H/L (Rs.) :
  • 169.65 - 162.25
  • 52wk H/L (Rs.) :
  • 270.70 - 156.00
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Marksans Pharma Ltd.
PE Ratios
38.82
EPS (Rs.)
4.15
Sales (Rs. Cr)
339.73
Face Value (Rs.)
1
Net Profit Margin(%)
16.03
Last Bonus
-
Last Dividend(%)
80
Return on Average Equity
13.6

News for Marksans Pharma Ltd.

Unifi Capital Sells Marksans Pharma Stake
Unifi Capital sold a 1.6% stake in Marksans Pharma for nearly Rs 168 crore through an open market transaction. The shares were sold at an average price of Rs 231.50 apiece.
Jul 28, 2025 20:10
OrbiMed Sells Marksans Pharma Stake for Rs 257 Cr
OrbiMed divested a 2.27% stake in Marksans Pharma for Rs 257 crore through an open market transaction. The sale reduced OrbiMed's holding to 8.61%.
Jun 11, 2025 22:28
Pharma Stocks Sink Amid US Tariff Threat
Indian pharma stocks plunged on Wednesday following reports that the US will soon announce tariffs on pharmaceutical imports. Blue Jet Healthcare, Marksans Pharma, Wockhardt, Glenmark...
Apr 09, 2025 17:55
Pharma Stocks Plunge on Trump Tariff Threat
Pharmaceutical stocks tumbled up to 10% after reports of Trump imposing tariffs on imports. Aurobindo, Laurus, Ipca, Lupin, Biocon, and Cipla were among the hardest hit.
Apr 04, 2025 12:03
Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment
Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.
Nov 22, 2024 17:30

More News for Marksans Pharma Ltd. »

News for Pharmaceuticals and health care

Silver Rebounds to Rs 2.4 Lakh/kg After 7-Day Slide
Silver futures rebound to Rs 2.4 lakh/kg on value buying, halting a 7-day losing streak. Learn about factors driving the price recovery.
Mar 20, 2026 11:42
HDFC Bank Shares Fall After Chairman Resigns
HDFC Bank shares decline after non-executive chairman Atanu Chakraborty resigns citing differences over values and ethics.
Mar 20, 2026 11:33
J&K to Host Kashmir Travel Mart 2026
J&K Tourism to host Kashmir Travel Mart on April 14-15, 2026. Showcasing tourism potential, culture, heritage, and hospitality.
Mar 20, 2026 10:57
Rupee Hits Record Low: Breaches 93 Against US Dollar
Rupee falls to a record low of 93.08 against the US dollar amid strong greenback, FII outflows, and West Asia conflict.
Mar 20, 2026 09:58
Stock Markets Rebound After Sharp Fall
Sensex and Nifty rebound in early trade after a massive fall. Crude oil prices cool. Read more on market recovery and global cues.
Mar 20, 2026 09:58

More News »

Top News

Silver Rebounds to Rs 2.4 Lakh/kg After 7-Day Slide
Silver futures rebound to Rs 2.4 lakh/kg on value buying, halting a 7-day losing streak. Learn about factors driving the price recovery.
Mar 20, 2026 11:42
HDFC Bank Shares Fall After Chairman Resigns
HDFC Bank shares decline after non-executive chairman Atanu Chakraborty resigns citing differences over values and ethics.
Mar 20, 2026 11:33
J&K to Host Kashmir Travel Mart 2026
J&K Tourism to host Kashmir Travel Mart on April 14-15, 2026. Showcasing tourism potential, culture, heritage, and hospitality.
Mar 20, 2026 10:57
Rupee Hits Record Low: Breaches 93 Against US Dollar
Rupee falls to a record low of 93.08 against the US dollar amid strong greenback, FII outflows, and West Asia conflict.
Mar 20, 2026 09:58
Stock Markets Rebound After Sharp Fall
Sensex and Nifty rebound in early trade after a massive fall. Crude oil prices cool. Read more on market recovery and global cues.
Mar 20, 2026 09:58

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com